Microsoft word - dr. k full cv_ibt.com version.doc

Robert H. Keller, MD, MS, FACP, AAHIVS
• Education and Training
• Professional and Faculty Positions
• Hospital Staff Appointments
• Fellowships and Awards
• Grant Support During Academic Tenure
• Honors
• Invited Lectureships
• Editorial Boards / Reviews
• Consultantships
• Current Medical Licensure
• Certification
• Professional Societies
• Teaching Experience
• Invited Professional Lectures
• Committee Service
• Statement of Research Interest
• Patents Issued
• Provisional Patents
• Book Chapters
• Original Research Contributions and Invited Reviews
• Papers Submitted, In review and/or Revision
• ABSTRACTS
____________________________________________________________________________________ Robert H. Keller, MD, MS, FACP, AAHIVS

Education and Training:

1966 Bachelor of Arts in Biology
Master of Science in Biology Fordham University, Bronx, New York 1970 Doctor of Medicine (MD) with honors Temple University, Philadelphia, Pennsylvania 1970-1974 Internship, Resident and Senior Resident University of Rochester, Rochester, New York Department of Immunology Mayo Clinic, Rochester, Minnesota Mayo Graduate School of Medicine Rochester, Minnesota
Professional and Faculty Positions:
Phoenix BioSciences which has developed a new first in class and first in man viral-host interaction inhibitor for HIV / AIDS 1999- Chairmain,CEO and Director of Research Miami, Florida 1996- Chairman and CEO Immune Balance Technologies Hollywood, Florida 1994- Director of Medicine & Research Biodoron Medical Center Hollywood, Florida 1994-1995 Consultant in Immunology and Hematology Health Professionals, Inc and Center for Special Immunology 1992-1995 Director Immune Reconstitution Program Center for Special Immunology Center for Special Immunology Miami Beach, Florida 1987-1996 President and Medical Director The Wilson Bode Center Fort Lauderdale, Florida 1986-1987 Associate Director of Research and Development Coulter Immunology Coulter Electronics, Inc., Hialeah, Florida Wilson Bode Center for Hematology and Immunology Research Milwaukee, Wisconsin Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin 1982-1986 Associate Professor Departments of Medicine and Biophysics (Allergy and Immunology, Flow Cytometry) Medical College of Wisconsin Milwaukee, Wisconsin 1982-1986 Clinical Investigator and Staff Physician Midwest Children’s Cancer Center (Immunology, Flow Cytometry, Transplantation) Chief of Immunology Milwaukee Children’s Hospital Milwaukee, Wisconsin Department of Pediatrics (Hematology/Oncology, Immunology) Medical College of Wisconsin Milwaukee, Wisconsin Department of Health Sciences (Hematology, Immunology, Flow Cytometry) University of Wisconsin Milwaukee, Wisconsin 1978-1980 Research Associate and Staff Physician Research Service Zablocki VAMC Milwaukee, Wisconsin Department of Medicine (Hematology/Oncology) Medical College of Wisconsin Milwaukee, Wisconsin 1977 Assistant Professor Department of Immunology Mayo Medical School Rochester, Minnesota 1974-1977 Fellow and Senior Research Fellow in Immunology Mayo Clinic Foundation Mayo Graduate School of Medicine Rochester, Minnesota
Hospital Staff Appointments:
1976-1977 Mayo Clinic, Rochester, Minnesota
1977-1986 Zablocki VAMC, Milwaukee, Wisconsin
1977-1986 Milwaukee County Medical Complex, Milwaukee, Wisconsin
1992-1997 Mount Sinai Medical Center, Miami Beach, Florida
1992-1999 Cleveland Clinic Hospital, Fort Lauderdale, Florida
1992-1999 Miami Heart Institute, Miami Beach, Florida
1997-1999 Palmetto General Hospital, Hialeah, Florida
Broward General Medical Center, Fort Lauderdale, Florida 1997- Hollywood Medical Center, Hollywood, Florida 1997- South Shore Hospital, Miami Beach, Florida
1997- Memorial Medical Center, Hollywood, Florida
Fellowships and Awards:
1967-1969 Health Professions Scholarship
Temple University School of Medicine
1974-1975 Mayo Foundation Research Fellowship
Mayo Graduate School of Medicine
1975-1978 National Arthritis Foundation Fellowship 1978-1981 VA Career Development Award, Research Associate 1983-1986 VA Career Development Award, Clinical Investigator Grant Support During Academic Tenure
1978-1980 Alpha-fetoprotein Immunoregulation in a
Model of Murine Lymphoma
Veterans Administration Research
Principal Investigator $210,000
1981-1986 Immunoregulatory Dysfunction in
Non-Hodgkin’s Lymphoma
NIH, NCI Principal Investigator $430,000 1982-1986 Immunologic Studies of Environmental Lung Disease Co-Principal Investigator $525,000 1983-1986 VA Career Development Award 1984-1986 Clinical Applications of Laser Flow Cytometry Principal Investigator NIH (RR Shared Equipment Program) $105,609 1985-1986 Monoclonal Antibodies in the Detection of Cervical Carcinoma Co-Principal Investigator Hillman Foundation $85,000 1986-1987 Isoprinosine Modulation of the Immuno- regulatory Imbalances in AIDS and ARC Principal Investigator of FDA IND
Honors:
1970 Alpha Omega Alpha
1979 Superior Performance Award in Research 1991- Who’s Who in Science and Technology 1994- Who’s Who in the World HIV Medical Professional of the Year PWAC, Broward County, Florida Humanitarian of the Year National Hemophilia Foundation 2001- 2000 Outstanding Scientists of the 21st Century 2002 - 1000 Great Americans of the 21st Century America’s Top Physicians in Internal Medicine, Immunology and Hematology Academy of HIV Medicine of the State of Florida
2004 – 2006 AMA Physicians Recognition Award
2005 - Greatest Scholars of the Twenty First Century

Invited Lectureships:
1977 Second Fogarty International Conference on
Neonatal Liver Disease Baltimore, Maryland 1977 International Conference on the Diagnosis and Prevention of Neural Tube Defects Los Angeles, California 1977 Second International Conference on Diagnostic Immunology Heniker, New Hampshire 1979 Radioimmunochemical Detection of Cancer Albuquerque, New Mexico 1980 Visiting Professor of Hematology University of Mississippi University of California Irvine, California 1981 Third International Conference on Diagnostic Immunology, Section Chair 1982 Visiting Professor of Pathology University of Texas Medical Branch Galveston, Texas Wilfred Hall Air Force Research Center Galveston, Texas 1984 Visiting Professor Max Plank Institute for Biochemie Visiting Professor of Immunology and Pharmacology Piking Union Medical School (University of Beijing) Beijing, China
Editorial Boards / Reviews:

Diagnostic Immunology 1986-1990
Journal of Leukocyte Biology 1984-1986
Journal of Immunology 1990-Present
Consultantships:

Coulter Epics
Coulter Immunology
Corning Scientific
National Aeronautics and Space Administration (NASA)
Abbott HIV Advisory Board
Baxter Advisory Board for Hemophilia
Baxter Advisory Board for Hemophilia Inhibitor Patients
Underwriting Committee for Pronational Malpractice Insurance Company
Certifications:
National Board of Medical Examiners, 1971 and 1990
American Board of Internal Medicine, 1974 -
American Academy of HIV Medicine, 2001 -

Current Medical Licensure:
New York #112195
Wisconsin #19121
Florida #58991
Certification:
ACLS 1990 -
ATLS 1990 -

Professional Societies:
Alpha Omega Alpha
American Association for the Advancement of Science
American Association of Immunologists
American College of Physicians
American Federation of Clinical Research
American Society of Clinical Pathology
American Society of Hematology
International Society of Hematology
International Society of Hematopathology
International Immunocompromised Host Society
International Society of Analytical Cytology
Clinical Cytometry Society
New York Academy of Sciences
Clinical Immunology Society
National Organization for Rare Disorders
Teaching Experience:

1978-1980 Survey in Basic and Clinical Immunology Department of Medicine Medical College of Wisconsin 1980-1983 Principles of Laser Flow Cytometry Department of Health Sciences University of Wisconsin 1981 Special Topics in Immunology Immunoregulation in Cancer Department of Biology Marquette University 1983-1986 Co-Director Flow Cytometry Program University of Wisconsin Introduction to Flow Cytometric Analysis Principles of Image and Laser Cytometry Hybridomas and Monoclonal Antibodies Laboratory Evaluation of Immunoregulation Clinical Immunophenotyping and DNA Analysis Advanced Cytometry Advanced Cytometric Techniques

Invited Professional Lectures:

Dr. Keller has been the invited speaker at more than 1500 state, regional, national, and international, medical and scientific seminars and workshops in the fields of: AIDS and Immunoregulation Clinical Immunology Chronic Fatigue Syndrome Nutrition and the Immune Response Hormones and the Immune Response Hepatitis C Hemophilia 2000 Host of Today’s Health, WAXY 790 and Web streamed at Vitimmune.com Host of Voice America Web Based Healthcare Hour
Committee Service:
Veterans Administration: 1985-1986 Research and Development
Committee
Clement J. Zablocki VAMC
1986-1989 VA Oncology Merit Review Board
International Society for Analytical Cytology: 1984-1986 Research and Development
Committee: Controls & Standard
University of Wisconsin: 1983-1986 Flow Cytometry Evaluation
Committee, Co Chair
National Institutes of Health: 1983-1986 NIH Immunology Special
Study Section
Medical College of Wisconsin: 1980-1982 Faculty Welfare Committee
1980-1982 Animal Care Committee
1982-1986 Flow Cytometry Protocol Committee, Chair Cancer Committee for Hollywood Medical Center 1992- Pro-national Committee for Life Insurance Committee of Ten Thousand: 1998- Medical Advisory Board
National Hemophilia Federation: 1996- Medical Advisory Committee
National Hemophilia Foundation-Florida Chapter: 1994- Medical Advisory Committee
Mount Sinai Medical Center 1994-1997 Cancer Committee
Hollywood Medical Center 2001- Cancer Committee
Board of Governors American Academy HIV Med (FL) 2003 –
ProAssurance Malpractice Insurance Company 2005-
AAHIVM Clinical Practice Committee 2005-
Statement of Research Interest:

HIV: Dissection of the immune pertubations associated with HIV infection including therapy with experimental immunomodulary agents. Dissection of the immune perturbations associated with hemophiliac complications and therapeutic intervention using experimental immunoregulatory agents. Creation and utilization of unique `designer` monoclonal antibodies for the diagnosis, monitoring, imaging and therapy of human hematologic and solid tumor malignancies. Immune response and immunoregulation: dissection of the basic human immune response and the roles of cytokines and other regulatory molecules and the demonstration and characterization of aberrant responses in neoplastic and immunologic disease.

Book Chapters:

1) Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein: A Potential Regulator of Immune
Function. In Diseases of the Liver and Biliary Tract. Javitts, N.NIH, Bethesda,
Maryland, pp. 119-134, 1977.
2) Keller, R.H., Calvinico, N.J., Fink, J.N., and Stevens, J.O.: Immunobiologic Aspects
of Primate Hypersensitivity Pneumonitis. In Environmental Toxicology. Dungworth, D.L.
(ed), Academic Press, New York, pp.383-395, 1981.
3) Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: The Immunobiology of Human
Non-Hodgkin’s’ Lymphomas. In Clinical Cellular Immunology. Ludered, A. (ed).
Humana Press, New York, pp. 213-246, 1982.
4) Patrick, C.W., Keller, R.H., and Horan, P.K.: Flow Cytometry, Cell Sorting and
Hybridomas. American Society Clinical Pathology Press. St. Louis, MO, pp.
1-182, 1982.
5) Patrick, C.W., Parker, J., Keller, R.H., and Horan, P.K.: The Clinical Utility of
Monoclonal Antibodies and Immunophenotyping. In Flow Cytometry and Cell
Sorting in Hematologic Disease. American Society of American Pathologists Press.
Chicago, IL pp. 1-191.
6) Calvinico, N.J., Fink, J.N., and Keller, R.H.: Hypersensitivity Pneumonitis. In
The Immunology of the Lung. Bienenstock, J. (ed), Academic Press, New York 7) Keller, R.H., Milson, T.J., Janicek, K.M., Patrick, L.C., Sohnle, P., and Patrick, C.W.: Clinical Utilization of the Technicon H-6000 Flow Cytochemical Flow System
in Allergy Testing. In Proceedings of the 4th International Technicon Hematology
Colloquium. Simson, E. (ed) Academic Press, New York, pp 179-188, 1984.
8) Patrick, C.W., Horan, P.K, and Keller, R.H.: Immunophenotypic and Functional
Analysis Using Laser Flow Cytometry: Clinical Utility. American Society of
Clinical Pathology Press, Chicago, IL, 1985, pp. 1-168.
9) Patrick, C.W. and Keller, R.H.: Lymphocytes: Biochemistry, Physiology,
Function, and Morphology. In Principles of Hematology: Clinical and
Laboratory Practice. R.L. Bick, (ed) C.V. Mosby, St. Louis, MO in press.
10) Patrick, C.W. and Keller, R.H.: The Emerging Role of Laser Flow Cytometry
and Monoclonal Antibodies in Clinical Medicine. In: Principles of Hematology:
Clinical Laboratory Practice. R.L. Bick (ed) C.V. Mosby, St. Louis, MO, in press.
11) Keller, R.H. and Patrick, C.W.: Characterization of the Human Myeloid
Series by Monoclonal Antibodies. In Monoclonal Antibodies in Laboratory
Medicine. Swartz, M. (ed) Academic Press, New York, in press.
12) Patrick, C.W., McFadden, P.W., and Keller, R.H.: Immunophenotypic Analysis
of Human Bone Marrow Employing Monoclonal Antibodies and Laser Flow
Cytometry. In Proceedings of the Second International Conference on
Technological Advances in Laboratory Hematology. Howen, B. (ed),
Academic Press, 1985.
13) Keller, R.H., Janicek, K.M., and Patrick, C.W.: The Clinical Significance of
Laser Flow Cytometry DNA Analysis. In Proceedings of the Second
International Conference on Technological Advances in Laboratory
Hematology. Howen, B. (ed) Academic Press, New York, 1985.
14) Keller, R.H., Van Riel, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G,
Fletcher, M.A.: Association of Histocompatability Class II Antigens wit the
Chronic Fatigue Immune Dysfunction Syndrome. In Clinical Infectious
Disease. University of Chicago, Chicago, IL, 1994:18 (Supp 1): S154-6.
15) Antioxidants and the skin, A Paradigm for aging.
R.H. Keller and E. Arrayove (in press) 2004

Original Research Contributions and Invited Reviews:

1) Keller, R.H. and Tomasi, T.B.: Alpha-fetoprotein, E-Rosette Formation and
Tumor Cell Growth. N Engl J Med 293(24): 1265-1266, 1975.

2) Tomasi, T.B., Dattwyler, R., Murgita, R. and Keller, R.H.: Immunosuppression
by Alpha-fetoprotein. Trans Am Assoc Phys. 88:293-298, 1976.

3) Geubel, A.P., Keller, R.H., Summerskill, W.H.J., Dickson, E.R., Tomasi, T.B.
and Shorter, R.G.: Lymphocyte Cytotoxicity and Inhibition Studied with
Autologous Liver Cells: Observation in Chronic Acute Liver Disease and the
Primary Biliary Cirrhosis Syndrome. Gasterenterol. 71:450-459, 1976.

4) Keller, R.H. and Clavanico, N.J., and Tomasi, T.B.: Immunosuppressive
Properties of AFP: Role of Estrogens. In Onco Developmental Gene Expression.
Fichman, W.H. and Sell, S. (eds) Academic Press, New York, p.278, 1976.
5) Keller, R.H. and Tomasi, T.B.: Synthesis of Alpha-fetoprotein by Murine
Lymphoid Cells in Allogenic Reactions. J Exp Med 143:1120, 1976.

6) Banks, P., Keller, R.H., Li, V.Y. and White, E.B.: Malignant Lymphomas of
Plasmablastic Identity: A Neoplasm with Both “Immunoblastic” and Plasma
Cell Features. Am J Med 64:609-610, 1978.
7) Keller, R.H., Atwater, J.S., Martin, R.S. and Tomasi, T.B.: Ataxia Telangiectasia,
Immunosuppression and AFP: Is There a Relationship? In Prevention of Neural
Tube Defects. Crandall, B. (ed) Academic Press, New York, pp.27-40, 1978.
8) Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J.,
Brodky, F., Lynch, J., Rankin, L. and Malony, K.: Carcinoembryonic Antigen
(CEA) and Alpha-fetoprotein (AFP) in Cancer-Prone Families: Communicable
Implications. In Proceeding of the Third Annual Symposium on the Detection and
Prevention of Cancer. Part I (2), 1987.
9) Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha-fetoprotein in
Human Lymphoproliferative Disease. J Lab Clin Immunol, 2:93-98, 1979.

10) Kaplan, H.J., Meredith, T.A., Aeberg, T.M. and Keller, R.H.: Intraocular
Reticulum Cell Sarcoma (Histiocytic Lymphoma) in Richter’s Syndrome: A
Neoplasm of the Immune System. Arch Opthal 98:707-710, 1980.

11) Keller, R.H., Blake, B.G., Lyman, S. and Siebenlist, R.: Immunoregulatory
Abnormalities in Chronic Lymphocytic Leukemia. J Lab Clin Immunol 6:201-
208, 1981.
12) Choi, H. and Keller, R.H.: Co-existence of Chronic Lymphocytic Leukemia and
Hodgkin’s Disease. Cancer 48:48-55, 1981.
13) Kaplan, H.J., Aeberg, T.M. and Keller, R.H.: Etiology of Recurrent Clinical
Uveitis. Ber Dtsch Ophthal Ges 78:159, 1981.

14) Kaplan, H.J. and Keller, R.H.: Recurrent Clinical Uveitis: Cell Surface Markers on
Vitreous Lymphocytes. Arch Ophthal 100:585-592, 1982

15) Keller, R.H., Fink, J.N., Lyman, S. and Pederson, G.: Suppressor Cells in
Asymptomatic Pigeon Breeders. J Clin Immunol 2:46-51, 1982.
16) Milson, T.J., Grief, D. and Keller, R.H.: The Variable Effect of
Cryopreservation on Peripheral Blood Mononuclear Populations. J Clin Lab
Immunol 7:205-218, 1982.
17) Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Hypersensitivity Pneumonitis
In Non-human Primates. In Studies on the Relationship of Immunoregulation and
Disease Activity. J Immunol 128:116-123, 1982.
18) Keller, R.H.: Alpha-fetoprotein: Biologic and Clinical Potential. In Tumor Imaging:
The Radioimmunochemical Detection of Cancer. Burchiel, S. and Rhodes, B.
(eds) Mason Publishing, New York, pp. 179-188, 1982.
19) Patrick, C.W. and Keller, R.H.: New Techniques in the Diagnosis of
Hematopoietic Malignancies: Monoclonal Antibodies, Flow Cytometry and Cell
Sorting. Am Soc Clin Pathol Sp Topic Series 20(3)106-109, 1982.

20) Keller, R.H., Libnoch, J.A., Patrick, C.W., Blake, D.G., Choi, H. and Hanson,
R.D.: Fc Gamma Bearing T Cells in Non-Hodgkin’s Lymphomas. Diag Immunol
1:27-32, 1983.
21) Keller, R.H., Feldman, E. and Libnoch, J.A.: Immunoregulatory Abnormalities in the
Kindred of Waldenstrum’s Macroglobulinemia Patients. Am J Hematol
14:15-22, 1983.
22) Keller, R.H. and Calvanico, N.J.: Suppressor Macro-molecules. Crit Rev
Immunol 5(2): 149-199, 1984.
23) Fudenberg, H.H., Wilson, G.B., Keller, R.H., Metcalf, J.F., Pauling, E.E., Stuart,
E.J. and Floyd, E.: Clinical Application of the Leukocyte Migration Inhibition
Assay: New Methods for Determining Transfer Factor Potency and for Prediction
of Clinical Response. In Proceedings of the IV International Conference on
Transfer Factor. Academic Press, New York, pp. 293-310, 1984.
24) Patrick, C.W. and Keller, R.H.: A Simple Device for the Collection of Cells
Sorted by Flow Cytometry: Preservation of Integrity and Viability. Cytometry
5(3):308-311, 1984.
25) Keller, R.H., Milson, T.J., Janicek, K.M. and Patrick, C.W.: Monoclonal
Antibodies: Clinical Utility and the Misunderstood Epitope. Lab Med
15(12):785-802, 1984.
26) Keller, R.H., Swartz, S.J., Leven, S., Bar Sella, S. and Fink, J.N.:
Immunoregulation in Hypersensitivity Pneumonitis: Phenotypic and Functional
Studies of Bronchoalveolar Lavage Lymphocytes. Am Rev Resp Dis 130:766-771,
1984.
27) Patrick, C.W., Swartz, S.J., Harrison, K.A. and Keller, R.H.: Collection and
Preparation of Hemopoietic Cells for Cell Marker Analysis. Lab Med 15(10):
659-665, 1984.
28) Patrick, C.W., Milson, T.J., McFadden, P.W. and Keller, R.H.: Flow
Cytometry and Cell Sorting. Lab Med 15(11):740-745, 1984.
29) Wilson, G.B., Fudenberg, H.H. and Keller, R.H.: Guidelines for
Immunotherapy of Antigen Specific Defects with Transfer Factor. J Clin
Lab Immunol 13:51-58, 1984.

30) Baumann, M.A., Libnoch, J.A., Patrick, C.W., Choi, H. and Keller, R.H.:
Prolonged Survival in Richter’s Syndrome with Subsequent Re-emergence of
Chronic Lymphocytic Leukemia: A Case Report Including Serial Cell Surface
Phenotype Analysis. Am J Hematol 20:67-72, 1985.

31) Marti, G.E., Patrick, C.W., Muirhead, K., Magruder, L., Vail, M., Schuette,
W., Keller, R.H., Horan, P.K. and Gralnick, H.R.: Normal Blood Density
Gradient Lymphocyte Subset Analysis: In an Inter-Laboratory Flow Cytometric
Comparison of 85 Normal Adults. Am J Hematol 20:41-52, 1985.

32) Milson, T.J., Patrick, C.W., Sohnle, P.G., Patrick, L.C. and Keller, R.H.: Flow
Cytochemical Analysis of Atopic Reactions. Diag Immunol 3:182-186, 1986.
33) Milson, T.J., Patrick, C.W., Torke, N.J. and Keller, R.H.: Holding Media for Cell
Surface Phenotyping Analysis. J Immunol Methods 87:155-159, 1986.

34) Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.:
Immunoregulatory Abnormalities in Myelodysplastic Disorders. Am K Hematol
22:79-86, 1986.
35) Hansen, R.M, Lerner, N., Abrams, R.A., Patrick, C.W., Malik, M.I. and Keller,
R.H.: Chronic Lymphocytic Leukemia with Pure Red Cell Aplasia: Laboratory
Demonstration of Persistent Leukemia in Spite of Apparent Complete Clinical
Remission. Am J Hematol 22:79-86, 1986.

36) Baumann, M.A., Keller, R.H., McFadden, P.W., Libnoch, J.A. and Patrick, C.W.:
Myeloid Cell Surface Phenotype in Myelodysplasia: Evidence for Abnormal
Persistence of an Early Myeloid Differentiation Antigen. Am J Hematol
23:22-26, 1986.
37) Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.:
Correlation of Numbers of Natural Killer Cells with Clinical Course in Large
Cell Lymphoma. Cancer 57:2309-2312, 1986.
38) Patrick, C.W., Ash, R., Libnoch, J.A. and Keller, R.H.: Clinical Cytometry and
Immunophenotyping: I. Flow Cytometric Analysis of Normal Peripheral Blood and
Bone Marrow. Path Immunopathol Res 6:64-76, 1987.
39) Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.: Sequential
Immunophenotypic Studies in Chronic Lymphocytic Leukemia: UCLA
Molecular Biology Symposium. Chronic Lymphocytic Leukemia: Recent
Progress-Future Directions. R. Gale and K. Rai (eds) Alan R. Liss, New
York, 59, 1987.
40) Keller, R.H., Libnoch, J.A., Kallas, G.A., and Patrick, C.W.: Sequential
Evaluation of T Cell Subsets in B-CLL. UCLA Molecular Biology Symposium:
Chronic Lymphocytic Leukemia: Recent Progress-Future Directions. R. Gale
and K. Rai (eds) Alan R. Liss, New York, 59, 1987.
41) Fudenberg, H.H, Whitten, H.D., Galbraith, G.M.P., Goust, J.M., Patrick,
C.W. and Keller, R.H.: Deficiency of ‘Interactive’ T Cells in Individuals with
Recurrent Infection: Effect of DLE-TF Therapy. Am J Med. In Press, 1994.

42) Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G.
and Fletcher, M.A.: Association of Histocompatability Class II Antigens with the
Chronic Fatigue Immune Dysfunction Syndrome. In Clin Inf Disease 18(Supp 1):
S154-156, 1994.

Papers Submitted, In review and/or Revision

Patrick, C.W. and Keller, R.H.: A Comparative Study of Anticoagulants in
Cell Surface Maker Phenotyping and Functional Analysis. Am J Clin Pathol.
Keller, R.H., Milson, T.J. and Patrick, C.W.: Sequential Immunoregulatory
Phenotypic and Functional Changes During Viral Illness: A Comparison of
Rhinoviral Infection and Acquire Immunodeficiency Syndrome. Lancet (in
Revision).
Keller, R.H., Choi, H., Libnoch, J.A. and Patrick, C.W.: A Natural Murine
Model of Non-Hodgkin’s Lymphoma. J Immunol (in revision).
Choi, H., Libnoch, J.A., Aimargo, U., Heckman, M. and Keller, R.H.: Castelman’s Tumor: Well Differentiated Lymphocytic Lymphoma and
Large Cell Lymphoma in a Single Patient. Human Pathol (in revision).
Keller R.H., Wen K., and Kirchenbaum G. ALL-ergese a TCM blend of standardized herbs for the treatment of allergies. (in revision)
ABSTRACTS: Asterisks (*) denote those papers selected for presentation at national

1)* Keller, R.H., Dattwyler, R.J., Harrison, E. and Tomasi, T.B.: Alpha-
fetoprotein in Human Lymphoproliferative Disease. Blood 46(4):1035,
1975.
2)* Guebel, A.P., Keller, R.H., Summerskill, W.H.J., Tomasi, T.B. and Shorter,
R.G.: Cytotoxicity of Autologous and Normal Lymphocytes Against Isolated
Liver Cells in Patients with Primary Biliary Cirrhosis. Gastroenterol 68:104, 1975.
3)* Keller, R.H., Summerskill, W.H.J., Guebel, A.P., Shorter, R.G., and Tomasi,
T.B.: Alpha-fetoprotein and Suppression of Cell Mediated Immunity in
Chronic Acute Liver Disease (CALD). Gastroenterol 70:A-43:901, 1976.
4)* Keller, R.H, Guirgis, H., Lynch, H. and Tomasi, T.B.: Alpha-fetoprotein
(AFP) in Cancer Prone Families. Clin Res 24:331, 1976.
5)* Keller, R.H., Burritt, M.F., Thompson, R.L. and Tomasi, T.B.: Alpha-fetoprotein
(AFP): Synthesis in Allogeneic Reactions. Clin Res 24:447, 1976.
6)* Keller, R.H., Burritt, M.F. and Tomasi, T.B.: Alpha-fetoprotein (AFP)
Synthesis in Allogeneic Reactions. Eleventh Leukocyte Culture Conference,
Tucson, AZ, September 1976.
7)* Guirgis, H.A., Lynch, H.T., Keller, R.H., Tomasi, T.B., Vandervoorde, J.,
Lynch, J., Rankin, L., Maoney, K. and Harris, R.: Carcinoembryonic Antigen
(CEA) and Alpha-fetoprotein (AFP) in Cancer Prone Families. In Proceedings
of the Scientific Session of the Third International Symposium on the Detection
and Prevention, 1976.
8)* Vogten, A.J.M., Shorter, R.G., Summerskill, W.M.J., Keller, R.H. and Tomasi,
T.B.: Cell Mediated Cytotoxicity Against Human Liver Lipoprotein in Liver
Disease. Gastroenterol 71:A-41:934, 1976.
9)* Keller, R.H. and Tomasi, T.B.: AFP: A Potential Regulator of Immune
Function. Second International Conference on Disease of the Liver. Bethesda,
MA, March 1977.
10) Keller, R.H., Blake, D.G., Lyman, S., Libnoch, J.A. and Fabiance, M.:
Suppressor Cells in Asymptomatic Chronic Lymphocytic Leukemia. Clin Res
27:298, 1979.
11) Keller, R.H., Blake, D.G., Lyman, S. and Siebenlist, R.: Altered
Immunoregulation in Chronic Lymphocytic Leukemia. Blood 54:97A, 1979.
12) Blake, D.G., Libnoch, J.A., Lyman, S. and Keller, R.H.: Altered
Immunologic Reactivity in Myelodysplastic Disorders. Blood, 54:97A, 1979.
13)* Miller, P.P, Jordan, R.E. and Keller, R.H.: Suppression of Human
Lymphocyte Response by Circulating Immune Complexes. Clin Res 28:
351, 1980.
14)* Keller, R.H., Fink, N.J., Lyman, S. and Pederson, G.: Altered
Immunoregulation in Hypersensitivity Pneumonitis. Clin Res 28:102, 1980.
15)* Keller, R.H., Lyman, S. and Siebenlist, R.: The Influence of Human
Mononuclear Cell Histamine Production on T Cell Immunoregulation. Clin
Res 28:230, 1980.
16)* Keller, R.H., Lyman, S. and Siebenlist, R.: Histamine in the Immune
Response. 4th World Congress of Immunology, Paris, France. July 1980.
17)* Kaplan, H.J., Asberg, T.M. and Keller, R.H.: Lymphocyte Subset in Clinical
Uveitis. Abs Assoc Res Vision Opthal p. 33, 1980.
18)* Siebenlist, R., Calvanico, N.J., Stevens, J.O. and Keller, R.H.:
Immunoregulation in Hypersensitivity Pneumonitis. Fourth Midwest Autumn
Immunology Conference, Chicago, IL, 1980.
19)* Lyman, S., Patrick, C.W. and Keller, R.H.: Non-Hodgkin’s Lymphoma in the
Mouse: A Naturally Occurring Murine Model of NHL. Fourth Midwest Autumn
Immunology Conference, Chicago, IL, 1980.
20)* Young, D.G., Hussey, C.V., Keller, R.H. and Pisciotta, A.V.: Eradication of
Acquired Factor VII Inhibitor in Hodgkin’s Disease Following Chemotherapy.
Am Fed Clin Res 28(4):731, 1980.
21)* Keller, R.H., Patrick, C.W., Swartz, S.J., Libnoch, J.A. and Jordan, R.E.: Flow
Cytometry as an Adjunct in the Diagnosis and Staging of Lymphoproliferative
Disease. IX International Conference on Analytical Cytology. Schloss
Elmau, Germany, 1980.
22)* Wilson, R.J., Greiff, D. and Keller, R.H.: Cryopreservation of Non-specific T
Cell Suppressor Cells. Cryobiol 17:597, 1980.

23)* Pontzer, C. and Keller, R.H.: Rabbit Peripheral Blood T Cell Separation. Fed
Am Soc Exp Biol, 1980.
24)* Keller, R.H., Calvanico, N.J. and Stevens, J.O.: Immunoregulation in Pigeon
Breeders Disease. Clin Res 29:370, 1981.
25)* Keller, R.H., Kirchner, P., Lyman, S., Siebenlist, R., Choi, H. and Patrick, C.W.:
Immunoregulatory T Cells in Non-Hodgkin’s Lymphomas. Blood 58:313, 1981.
26)* Keller, R.H., Lyman, S., Choi, H. and Patrick, C.W.: A Natural Model of Non-
Hodgkin’s Lymphoma. Blood 58:524, 1981.
27)* Lauer, S., Casper, J., Keller, R.H., Kirchner, P. and Camitta, B.: The Use of
Counterflow Centrifugation-Elutriation for the Separation of Bone Marrow
Lymphoid Cells in Children with Acute Lymphocytic Leukemia (ALL) and
Metastatic Solid Tumors. Blood 58:133, 1981.
28)* Keller, R.H., Choi, H. and Patrick, C.W.: Nodular Non-Hodgkin’s Lymphoma in
the Mouse. Blood 60:114A, 1982.
29)* Keller, R.H., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood Aneuploidy in
Mycosis Fungoides and Pre-mycotic Lesions. Blood 60:146A, 1982.
30)* Keller, R.H., Swartz, S.J., Lyons, M., Troy, J. and Jordan, R.E.: Peripheral Blood
Involvement in Skin-limited T Cell Malignancy. Am Fed Clin Res 31:568, 1983.
31)* Geoghegan, W.D., Jordan, R.E. and Keller, R.H.: Non-Langerhans Cells in the
Keratinocyte Band in Culture Expressing HLA-DR. Invest Derm Am Fed Clin Res
31:568, 1983.
32)* Keller, R.H., Swartz, S.J., Patrick, C.W. and Kaplan, H.J.: Intraocular Lymphoma:
A Possible Systemic Disease. Am Fed Clin Res 31:315, 1983.
33)* Patrick, C.W., Libnoch, J.A., Choi, H. and Keller, R.H.: Flow Cytometric
Peripheral Blood Cell Surface Analysis as a Predictor of Richter’s Syndrome
(RS) in Chronic Lymphocytic Leukemia. Blood 62:756, 1983.
34)* Patrick, C.W., Swartz, S.J. and Keller, R.H.: A Comparative Study of Heparin
and Potassium EDTA as Anticoagulants for Cell Surface Marker and Immunologic
Functional Analysis. Am J Clin Pathol, 1983.
35)* Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke, N.J.:
Regression of Natural Murine Non-Hodgkin’s Lymphoma Following
Immunotherapy with Immunoregulatory Cell Types. Blood 62:756, 1983.
36)* Keller, R.H., Wagner, D. and Patrick, C.W.: Sequential T Cell Phenotypic and
Functional Changes During a Comparative Study of Rhinovirus Infection in
Patients with the Acquired Immune Deficiency Syndrome (AIDS). Blood
62:352, 1983.
37)* Keller, R.H., Swartz, S.J. and Patrick, C.W.: Metachromatic Granules in Human
T8 (CD8) Bearing Lymphocytes. Fifth World Congress of Immunology. Tokyo,
Japan. July 1983.
38) Libnoch, J.A., Patrick, C.W., Griffin, J. and Keller, R.H.: Flow Cytometric Cell
Surface Analysis as a Predictor of Leukemic Transformation in the Myeo-dyplastic
Syndrome (MDS). Blood 62:610A, 1983.
39)* Calvanico, N.J., Pontzer, C. and Keller, R.H.: Regulation of Aerosol Induced
Pulmonary Inflammation in Rabbits. XII Congress of the European Academy of
Allergy and Clinical Immunology, Rome, Italy, 1983.
40)* Patrick, C.W., Swartz, S.J., McFadden, P.W., Wallace, A. and Keller, R.H.: A
Comparative Study of Manual and Flow Cytometry Cell Surface Marker Analysis.
Soc Analytical Cytology, Sea Island, Georgia, 1983.
41)* Keller, R.H., Swartz, S.J., Troy, J., Patrick, C.W. and Jordan, R.E.: Peripheral
Blood Involvement in Skin Limited T Cell Malignancy. Soc Analytical
Cytology, Sea Island, Georgia, 1983.
42)* Keller, R.H., Swartz, S.J., Leven, S. and Bar Sella, S.: Immunoregulation in
Hypersensitivity Pneumonitis: Phenotypic and Functional Studies of
Bronchoalveolar Lavage Lymphocytes. Am Acd Allergy 130:766-771, 1984.
43)* Keller, R.H., Swartz, S.J., McFadden, P.W., Milson, T.J., Hermann, J., Thomas,
E. and Patrick, C.W.: Abnormal Peripheral Blood T Cell DNA Content in Skin
Limited T Cell Malignancy. Second International Conference on Malignant
Lymphoma, Lugano, Switzerland, June 1984.
44) Patrick, C.W., Harrison, K.A, Libnoch, J.A., Cozine, M.G. and Keller, R.H.:
Monoclonal Antibody Profiles in Human B Cell Lymphoproliferative Disorders
Suggests that B4 Positive Lymphocytes which Lack Expression of B1 Antigen
May Include the B Memory Cells. Second International Conference on Malignant
Lymphoma, Lugano, Switzerland, June 1984.
45)* Patrick, C.W., McFadden, P.W., Buchholz, T.B., Milson, T.J., Libnoch, J.A. and
Keller, R.H.: The Non-relevance of T4 to T8 (CD4:CD8) Ratios to Disease
Activity in B Cell Malignancies. Second International Conference on Malignant
Lymphoma, Lugano, Switzerland, June 1984.

46)* Keller, R.H., Swartz, S.J., Patrick, C.W., Steven, G. and Torke, N.J.:
Treatment of Naturally Occurring Murine Non-Hodgkin’s Lymphomas
Using Immunoregulatory Cell Types and IL-2. Second International
Conference Malignant Lymphoma, Lugano, Switzerland, June 1984.
47)* Kissebah, A.H., James, R. Krakower, G., Arnaud, C., Etienne, J. and Keller,
R.H.: Holding Media for Cell Surface Phenotypic Analysis. Midwest Autumn
Conference, Chicago, IL, November 1984.
48)* Milson, T.J., Patrick, C.W., Torke, N.J., Janicek, K.M., Harrison, K.A. and Keller,
R.H.: Alterations in Lymphoid and Myeloid Cell Surface Marker Phenotype
Profiles Associated with the Development of Basophilic Crisis in Chronic
Granulocytic Leukemia (Ph + CGL). Blood 64(5):195A, 1984
49)* Patrick, C.W., Libnoch, J.A., Milson, T.J., Kortright, K.H. and Keller, R.H.:
Common Variant of B Cell Chronic Lymphocytic Leukemia is Defined by the
Monoclonal Antibody TQ1 (Leu 8). Blood 65(5):149, 1984.
50)* Baumann, M.A., Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Myeloid and
Lymphoid Cell Surface Phenotype in Myelodysplasia: Correlation with In
Vitro Assessment of Immune Function. Blood 64(5):186A, 1984.
51)* Keller, R.H., Larrick, J.W., Swartz, S.J., Torke, N.J. and Patrick, C.W.:
Treatment of a Natural Model of Murine Non-Hodgkin’s Lymphoma with
Recombination Interleukin 2(IL-2). Blood 64(5):181, 1984.
52)* Steven, G.C., Choi, H., Heckman, M.G. and Keller, R.H.: Comparison of
Flow Cytometry and In sit Cell Surface Marker Analysis. Midwest Student
Research Forum XVI, Wright State University, February 1985.
53)* Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller,
R.H.: Regional Differences in Preadiopocyte Growth Potential from Immature and
Sexually Mature Female Rats. Am Fed Clin Res 33:434, 1985.
54)* Kissebah, A.H., Krakower, G., James, R., Aranaud, C., Etienne, J. and Keller,
R.H.: Regional Specialization of Subcutaneous Tissue Growth Potential:
Relationship to Ovarian Function. Am Diabetes Assoc, Toronto, Canada,
November 1985.
55)* Baumann, M.A., Milson, T.J., Patrick, C.W., Libnoch, J.A. and Keller, R.H.:
Correlation of Natural Killer Cell Count with Prognosis in Large Cell
Lymphoma. Blood 66:185, 1985.
56)* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of Dual
Immunofluorescence Assay of Monoclonal Antibodies TQ1 and (CD19)
on Peripheral Blood Cells in Chronic Lymphocytic Leukemia. Blood 66:
181, 1985.
57)* Patrick, C.W., Libnoch, J.A., Baumann, M.A. and Keller, R.H.: Alterations of
Myeloid Surface Receptors recognized by the Monoclonal Antibody MY 9
(CD33) in the Peripheral Blood May Serve to Identify Those Myelodysplastic
Patients at Increased Risk for Leukemic Conversion. Blood 66:226, 1985.
58) Keller, R.H., Milson, T.J., McFadden, P.W. and Patrick, C.W.: In Vitro
Augmentation of Immunologic Responsiveness in Patients with AIDS and
ARC Using Isoprinosine. Blood 66:113, 1985.
59) Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments In Vitro
Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia. Blood 66:202,
1985.
60)* Keller, R.H., Patrick, L.C. and Patrick, C.W.: Isoprinosine Augments In Vitro
Immunoglobulin Synthesis in Chronic Lymphocytic Leukemia (B-CLL).
International Symposium on Recent Approaches to Chronic Lymphoproliferative
Disease, Prague, Czechoslovakia, September 1985.
61)* Keller, R.H., Milson, T.J. and Patrick, C.W.: The Relationship of Larger
Lymphoid Elements, Clonally Restricted DNA Cell Cycle Analysis and Rai
Staging in Chronic Lymphocytic Leukemia (B-CLL). International Symposium
on Recent Approaches to Chronic Lymphoproliferative Disease, Prague,
Czechoslovakia, September 1985.
62)* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Immunophenotypic Dissection of
Chronic Lymphocytic Leukemia. International Symposium on Recent Approaches to
Chronic Lymphoproliferative Disease, Prague, Czechoslovakia, September 1985.
63)* Keller, R.H., Libnoch, J.A., Patrick, L.C. and Patrick, C.W.: In Vitro
Improvement of Cellular and Humoral Immune Response by Isoprinosine in
B-CLL. XXI Congress of the International Society of Haematology, Sydney,
Australia, May 1986.
64)* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Prolymphocytic Leukemia of B
Cells is a Distinct Biologic Stage in B Cell Maturation. XXI Congress of the
International Society of Haematology, Sydney, Australia, May 1986.
65)* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Sequential Changes in the
Expression of Lymphoid Surface Membrane Receptors in Chronic B Cell
Lymphoproliferative Disease. XXI Congress of the International Society of
Haematology, Sydney, Australia, May 1986.
66)* Patrick, C.W., Libnoch, J.A. and Keller, R.H.: Clinical Utility of Dual
Immunofluorescence Assay of Monoclonal Antibodies TQ1 and B4 (CD19) on
Circulating B Cells in Chronic Lymphocytic Leukemia (B-CLL). Sixth
International Congress of Immunology, Toronto, Canada, July 1986.
67)* Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential
Clinical, Immunoregulatory, Phenotypic and Functional Changes in Patients
with AIDS and ARC treated with Isoprinosine. XXI Congress of the International
Society of Haematology, Sydney, Australia, May 1986.
68)* Keller, R.H., Milson, T.J., Ellingboe, K.M. and Patrick, C.W.: Sequential
Clinical, Immunoregulatory, Phenotypic and Functional Changes in Patients
with AIDS and ARC treated with Isoprinosine. International Conference on the
Acquired Immunodeficiency Syndrome, Paris, France, June 1986.
69)* Keller, R.H., Libnoch, J.A. and Patrick, C.W.: T Cell Alterations in B-CLL:
Sequential Changes in CD4 and CD8 Bearing Cells and in T Cell Immunoregulation.
UCLA Symposium on Molecular and Cell Biology, Silverado, California,
December 1986.
70)* Patrick, C.W., Libnoch, J.A., Kallas, G.A. and Keller, R.H.: Sequential
Immunophenotypic Studies in Chronic Lymphocytic Leukemia. UCLA
Symposium on Molecular and Cell Biology, Silverado, California, December
1986.
71)* Reiter, W.M., Berger, D.S., Vorce, S., Cimoch, P.J., Vargas, A. and Keller, R.H.:
Combination Zidovudine and Didanosine Therapy for Patients Remaining
Persistently HIV P24 Antigen-Positive Despite Zidovudine Monotherapy. VIII
International AIDS Conference, Amsterdam, Netherlands, 1992.
72)* Reiter, W.M., Keller, R.H., Cimoch, P.J. and Forgione, A.: A Rapid Quantitative
Flow Cytometry Assay to Evaluate CD4 + - Lymphocyte Activation Potential
in Patients with HIV-1 Infection. VIII International AIDS Conference, Amsterdam,
Netherlands, 1992.
73)* Cimoch, P.J., Reiter, W.M., Vorce, D., Cassarella, S.K., Thompson, B. and Keller,
R.H.: The Occurrence of Cytomegalovirus (CMV) Viruria in Late-Stage HIV-1
Infection and its Association with CMV Organ Involvement. VIII International
AIDS Conference, Amsterdam, Netherlands, 1992.
74)* Reiter, W.M., Beach, R.S., Vorce, D., Cimoch, P.J., Vargas, A., Thompson,
B. and Keller, R.H.: Longitudinal Analysis the Effect of Anti-retroviral
Monotherapy on CD4+ Lymphocyte Percentage. VIII International AIDS
Conference, Amsterdam, Netherlands, 1992.
75)* Keller, R.H., Van Reil, F., Maislis, J., Lane, J.T., Reiter, W.M., Klimas, N.G.
and Fletcher, M.A.: Correlation of DR4 and DQ1 with Immunologic Defects in the
Chronic Fatigue Syndrome. First International Chronic Fatigue Syndrome
Research Conference, Albany, New York, October 1992.
76)* Keller, R.H., Reiter, W.M., Lane, J.T., Klimas, N.G., Vargas, A. and Maislis, J.A.:
Treatment of Late-Stage AIDS Patients with Combined Monthly Anti-HIV
Hyperimmunoglobulins and Haplotype-matched Peripheral Blood Lymphocytes.
XI International Conference on AIDS, Berlin, 1993.
77) Reiter, W.M., Cimoch, P.J., Vorce, D.E., Keller, R.H., Berger, D. and Ping, A.:
Eighteen Month Longitudinal Analysis of the Effect of Zidovine Monotherapy
Compared to Combination Antiretroviral Therapy on HIV-1 Disease Progression.
IX International Conference on AIDS, Berlin 1993.
78)* Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H., Berger, D.S., and Ping, A.C.:
Cytotoxic CD8+ Lymphocyte Response to HIV-1 Infection Correlated with
Longitudinal Analysis of CD4+ Lymphocyte Percentage. IX International
Conference on AIDS, Berlin, 1993
79) Berger, D.S., Reiter, W.M., Vorce, D.E., Cimoch, P.J., Keller, R.H. and Ping,
A.C.: Prevalence of Red Blood Cell Magnesium Deficiency in HIV-1 Infected
Patients and its Association with Fatigue and Myalgia. IX International
Conference on AIDS, Berlin, 1993.
80) Reiter, W.M., Tomaka, F., Keller, R.H., Cimoch, P.J., Vargas, A. and Vorce, D.E.: Unrecognized Moderate to Advanced Immunodeficiency in “HIV-Aware”
Asymptomatic, Untreated Person with HIV-1 Infection. IX International
Conference on AIDS, Berlin, 1993.

81)* Gomatos, P.J., Keller, R.H., Reiter, W.M., Lane, J.T., Cimoch, P.J., Vorce,
D.E., Gianetti, B.L. and Uribe, M.R.: Haplotype-Matched Peripheral Blood
Mononuclear Cell (PBMC) Transfusions in Patients with Late-Stage AIDS.
X International Conference on AIDS, Yokohama, Japan, 1994.
82)* Cimoch, P.J., Loss, S.D., Houghton, R.A., Reiter, W.M., Keller, R.H., Vorce,
D.E., Nemecheck, P.M., Berger, D.S. and Tomaka, F.L.: Antibody Response to
Pneumococcal Vaccination in HIV-1 Infected Patients. X International
Conference on AIDS, Yokohama, Japan, 1994.
83)* Tomaka, F.L., Cimoch, P.J., Reiter, W.M., Keller, R.H., Berger, D.S.,
Piperato, J.R., Nemecheck, P.M., Loss, S.D. and Houghton, R.A.:
Prevalence of Nutritional Deficiencies in Patients with HIV-1 Infection. X
International Conference on AIDS, Yokohama, Japan, 1994.
84)* Keller, R.H., Helder, L.M., Piperato, J.P., Klimas, N.G., Reiter, W.M., Fletcher,
M.A., Vorce, D.E. and Pittibone, H.: Symptomatic Improvement Associated
with Down Regulation of Immune Hyper Reactivity by Calcium Channel
Blockade in CFIDs. American Association for Chronic Fatigue Syndrome
Research Conference, Ft Lauderdale, Florida, 1994.
85)* Keller, R.H., Nolan, R.P. and Patrick, L.C.: Natural Human Interferon (Alpha
Leukoferon) Therapy in a Cohort of Hemophiliacs Co-infected with HIV and
Hepatitis C. Fourth Conference on Retroviruses and Opportunistic Infections,
Washington, DC, 1997.
86)* Patrick, C.W. and Keller, R.H.: Patient Screening for Myelodysplasia in Long-
Term HIV+ Individuals. Conference on Clinical Laboratory Testing in HIV,
Atlanta, GA, 1998.
87)* Patrick, C.W., DeLeon, M., A. Leon, and Keller, R.H.: Measurement of
Glutathione (GSH) as Indicator of Immune Status. Conference on Clinical
Laboratory Testing in HIV, Atlanta, GA 1998.
88)** Kushch, A. and Keller, R.H.: Neuropsychological Correlates of Adjunct Therapy
with a Nutritional/Vitamin Supplement in a Medical Patient Sample.
National Academy of Neuropsychology, ** Orlando, FL, November 2000.
89) Keller, R.H.:PBS 119 Abstract “Clinical Results of PBS 119 in Eight Patients for Two
Years” Submitted to the 12th Conference on Retroviruses & Opportunistic Infections (CROI),
2005
90) Keller, R.H.: PBS 119 Abstract “In Vitro Analysis of PBS 119 Against HIV Viral Activity
in Lab Adapted and HAART Resistant Strains of HIV” Submitted to the 12th Conference
on Retroviruses & Opportunistic Infections (CROI), 2005

Source: http://3e.co.nz/pdf/keller_vitae.pdf